China Fabry Disease Therapeutics Market: Segmented by Therapy (Enzyme Replacement Therapy, Substrate Reduction Therapy, Chaperone Therapy), Route of Administration (Oral, Intravenous)- Size, Share, Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 139797
- Pages: 200
-
Format:
Report Overview
China Fabry Disease Therapeutics market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Fabry disease is a rare inherited disorder of glycosphingolipid (fat) metabolism resulting from the absent or markedly deficient activity of the lysosomal enzyme, -galactosidase A (-Gal A). The global incidence rate of Fabry diseaseis estimated to be 1 in every 40,000 to 60,000 persons. Women can also have the disease, but the prevalence is less known.
Market Drivers
China is a growing market for fabry disease due to increase in awareness of disease and improvement in R&D activities. Additionally, the increasing awareness about enzyme replacement therapy among consumers and rising healthcare expenditure towards research and development activities and the adoption of technologically advanced medical devices is expected to drive the market growth.
However, there are some restraining factors for the growth of Fabry disease therapeutics market in China such as high cost of treatment, limitations of medical insurance coverage and misdiagnosis of the disease.
1. China Fabry Disease Therapeutics Market Overview...............................................
A. Market Size
2. Market Growth Drivers
A. Increase in Awareness of Disease
B. Rise in Healthcare Expenditure
C. Improvement in R&D Activities
D. Adoption of Technologically Advanced Medical Device
3. Major Types of Fabry Disease.........
A. Type 1 Classic Phenotype
B. Type 2 Later-Onset Phenotype
4. Fabry Disease Therapeutics Market Segmentation
A. By Therapy
I. Enzyme Replacement Therapy
II. Chaperone Therapy
III. Substrate Reduction Therapy
B. By Route of Administration
I. Oral
II. Intravenous
5. Fabry Disease Major Products Market Share...
A. Market Analysis, Insights and Forecast By Revenue Type
6. Competitive Landscape.........
A. Major Players
B. Products in Pipeline
7. Key Company Profiles
A. Amicus Company Overview, Product & Services, Strategies & Financials
B. Sanofi Company Overview, Product & Services, Strategies & Financials
C. Takeda Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
9. Factors Driving Future Growth
A. New Trends and Development of Fabry Disease Therapeutics Market
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
